forex signal system trading: How traders can get in on the biotech boom

As you can see from this Wall Street Journal quote, Lou's hardly alone in turning to the biotech sector right now.

But there's a big difference between Lou and all the other investors out there: only Lou has a 7-Step System for identifying the best potential biotech stocks to trade.

And on June 23rd at 8:00pm ET, in a special LIVE broadcast, he's going to teach you his system. [By clicking this link, you'll automatically be opted into Lou's training event, as well as periodic updates from Lou's Trend Trader Daily e-letter (privacy policy)]

You see, Lou wants everyone to walk away from this event knowing his entire system: all seven steps, along with a blueprint for how they can apply it to their own trading.

But he also wants to go one step further: he wants to give away a free pick. This pick is one of his highest-conviction biotech trades right now — and he's giving away its name, ticker symbol, everything.

Click here to reserve a seat for Lou's LIVE Briefing »
[By clicking this link, you'll automatically be opted into Lou's training event, as well as periodic updates from Lou's Trend Trader Daily e-letter (privacy policy))

Best regards,

DISCLAIMER:

COMMUNICATIONS FROM GODESBURG FINANCIAL PUBLISHING (GFP) ARE FOR EDUCATIONAL AND INFORMATIONAL PURPOSES ONLY – NOT INVESTMENT ADVICE: GFP and all the services it offers are for educational and informational purposes only and should NOT be understood to be securities-related offers or solicitations. None of GFP's communications should be considered or used as personalized investment advice. GFP recommends that you speak with a licensed professional before making any investment decision.

RESULTS PRESENTED ARE NOT NECCESSARILY TYPICAL OR VERIFIED: GFP communications may include information regarding the historical trading performance of gurus in their services (all verified by a third party), as well as testimonials of non-employees depicting profitable investments and trades that are believed to be true based on the representations of the persons providing the testimonial of their own free will. Please be aware that the claims regarding investing or trading results of non-employees are not tracked by GFP nor can they be verified. As always, past performance is not necessarily indicative of future results. Therefore, results presented in this email should NOT be considered TYPICAL. Actual results can and will vary based on everything from experience, ability, risk mitigation practices, and market volatility... to the amount of money exposed in the investment or trade. Investing and trading are speculative and carry serious risk. You may lose some, all - or possibly more - than your original investment or trade.

GODESBURG FINANCIAL PUBLISHING IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER: GFP, including its owners and employees, are NOT registered as securities broker-dealers, brokers, or any sort of registered investment advisors with the U.S. Securities and Exchange Commission, any state securities regulatory authorities, or any self-regulatory organizations.

GODESBURG FINANCIAL PUBLISHING EMPLOYEES MAY HOLD SECURITIES DISCUSSED: If a writer holds any securities in a communication, it will be disclosed along with the information on the potential investment or trade. HIR, its owners or employees, have not been - or ever will be - paid by the issuer of a security mentioned in our services or communications. GFP, its owners and employees are paid entirely or in part from commissions based on sales of their services to subscribers.

For more information, please visit our disclaimer page here.

How traders can get in on the biotech boom

No comments:

Post a Comment